Cargando…
Subacute Toxicity Profile of Lacidipine Nanoformulation in Wistar Rats
The present study was aimed at investigating the safety of Lacidipine (LCDP) loaded nanostructured lipid carriers (NLCs) in Wistar rats. NLCs were formulated using ultrasound dispersion technique. Animals were orally treated once daily with NLCs containing 0.140 mg, 0.350 mg, and 0.875 mg of LCDP as...
Autores principales: | Shirodkar, Rupesh, Misra, Chandrasekhar, GH, Chethan, Shetty, Pallavi, Attari, Zenab, Mutalik, Srinivas, Lewis, Shaila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458540/ https://www.ncbi.nlm.nih.gov/pubmed/26101786 http://dx.doi.org/10.1155/2015/947623 |
Ejemplares similares
-
Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology
por: Attari, Zenab, et al.
Publicado: (2016) -
Acute and Subacute Toxicity Assessment of Oxyclozanide in Wistar Rats
por: Wang, Weiwei, et al.
Publicado: (2019) -
Corrigendum: Acute and subacute toxicity assessment of oxyclozanide in Wistar rats
por: Wang, Weiwei, et al.
Publicado: (2023) -
Antibacterial & antitoxic effects of the cardiovascular drug lacidipine in an animal model
por: Dasgupta, Asish, et al.
Publicado: (2012) -
Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats
por: Kamal, Sahar
Publicado: (2010)